XML 65 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Revenue Recognition and Accounts Receivables (Tables)
6 Months Ended
Dec. 31, 2014
Receivables [Abstract]  
Summary of Revenues Before Provision for Doubtful Accounts

Revenues before provision for doubtful accounts by payor were as follows for the three and six months ended December 31, 2014 and 2013:

 

     Three Months Ended      Six Months Ended  
     December 31,      December 31,  
     2014      2013      2014      2013  

Healthcare Facilities Segment:

           

Medicare

   $ 6,685       $ 6,516       $ 13,963       $ 13,623   

Medicaid

     3,602         3,524         6,971         6,844   

Self-pay

     2,002         2,453         3,990         4,705   

Managed Care & Other Insurance

     4,189         4,156         8,514         8,572   

Other

     43         45         96         98   
  

 

 

    

 

 

    

 

 

    

 

 

 

Revenues before provision for doubtful accounts

  16,521      16,694      33,534      33,842   

Provision for doubtful accounts

  (1,982   (2,231   (4,215   (4,288
  

 

 

    

 

 

    

 

 

    

 

 

 

Healthcare Facilities Segment Net Revenues

  14,539      14,463      29,319      29,554   

Specialty Pharmacy Segment Net Revenues

  8,430      9,326      15,884      16,168   

Other Revenues

  157      91      299      187   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Net Revenues

$ 23,126    $ 23,880    $ 45,502    $ 45,909   
  

 

 

    

 

 

    

 

 

    

 

 

 

Summary Information for Accounts Receivable

Summary information for accounts receivable is as follows:

 

     December 31,      June 30,  
     2014      2014  

Accounts receivable (net of contractual allowances)

   $ 18,394       $ 16,753   

Less allowance for doubtful accounts

     (7,279      (6,903
  

 

 

    

 

 

 

Patient accounts receivable—net

$ 11,115    $ 9,850   
  

 

 

    

 

 

 

Summary of Allowance for Doubtful Accounts

The following is a summary of the activity in the allowance for doubtful accounts for the Healthcare Facilities Segment and the Specialty Pharmacy Segment for the three and six months ended December 31, 2014:

 

     Healthcare      Specialty         
Three Months Ended December 31, 2014:    Facilities      Pharmacy      Total  

Balance at October 1, 2014

   $ 7,117       $ 213       $ 7,330   

Additions recognized as a reduction to revenues

     3,016         80         3,096   

Accounts written off, net of recoveries

     (3,078      (69      (3,147
  

 

 

    

 

 

    

 

 

 

Balance at December 31, 2014

$ 7,055    $ 224    $ 7,279   
  

 

 

    

 

 

    

 

 

 
     Healthcare      Specialty         
Six Months Ended December 31, 2014:    Facilities      Pharmacy      Total  

Balance at July 1, 2014

   $ 6,649       $ 254       $ 6,903   

Additions recognized as a reduction to revenues

     6,251         80         6,331   

Accounts written off, net of recoveries

     (5,845      (110      (5,955
  

 

 

    

 

 

    

 

 

 

Balance at December 31, 2014

$ 7,055    $ 224    $ 7,279   
  

 

 

    

 

 

    

 

 

 

 

     Healthcare      Specialty         
Three Months Ended December 31, 2013:    Facilities      Pharmacy      Total  

Balance at October 1, 2013

   $ 7,317       $ 482       $ 7,799   

Additions recognized as a reduction to revenues

     2,899         42         2,941   

Accounts written off, net of recoveries

     (3,456      (45      (3,501
  

 

 

    

 

 

    

 

 

 

Balance at December 31, 2013

$ 6,760    $ 479    $ 7,239   
  

 

 

    

 

 

    

 

 

 
     Healthcare      Specialty         
Six Months Ended December 31, 2013:    Facilities      Pharmacy      Total  

Balance at July 1, 2013

   $ 7,286       $ 475       $ 7,761   

Additions recognized as a reduction to revenues

     5,617         95         5,712   

Accounts written off, net of recoveries

     (6,143      (91      (6,234
  

 

 

    

 

 

    

 

 

 

Balance at December 31, 2013

$ 6,760    $ 479    $ 7,239